WFA of San Diego’s AbbVie ABBV Stock Holding History

WFA of San Diego’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$393K	Sell	1,568 -185	-11%	-$39.8K	0.32%	58
2026 Q1	$381K	Sell	1,753 -18	-1%	-$3.99K	0.31%	59
2025 Q4	$405K	Sell	1,771 -25	-1%	-$5.7K	0.3%	62
2025 Q3	$416K	Hold	1,796	–	–	0.28%	63
2025 Q2	$333K	Buy	+1,796	New	+$334K	0.25%	73
2024 Q3	$453K	Hold	2,296	–	–	0.38%	55
2024 Q2	$394K	Buy	+2,296	New	+$380K	0.35%	59
2023 Q3	$354K	Sell	2,372 -40	-2%	-$5.87K	0.37%	57
2023 Q2	$325K	Sell	2,412 -555	-19%	-$81.4K	0.32%	61
2023 Q1	$473K	Sell	2,967 -300	-9%	-$45.9K	0.49%	42
2022 Q4	$528K	Hold	3,267	–	–	0.4%	54
2022 Q3	$438K	Hold	3,267	–	–	0.39%	55
2022 Q2	$500K	Sell	3,267 -315	-9%	-$48.1K	0.43%	50
2022 Q1	$581K	Sell	3,582 -500	-12%	-$72.6K	0.44%	49
2021 Q4	$553K	Buy	4,082 +380	+10%	+$44.9K	0.32%	66
2021 Q3	$399K	Sell	3,702 -110	-3%	-$12.6K	0.28%	69
2021 Q2	$429K	Sell	3,812 -125	-3%	-$14.1K	0.33%	60
2021 Q1	$426K	Buy	+3,937	New	+$421K	0.35%	57
2020 Q4	–	Sell	-4,502	Closed	-$394K	–	91
2020 Q3	$394K	Sell	4,502 -5,632	-56%	-$530K	0.37%	52
2020 Q2	$943K	Buy	+10,134	New	+$892K	0.22%	106

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WFA of San Diego's ABBV Position: Q2 2026 in Review

WFA of San Diego reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $39.8K and leaving 1,568 shares worth $393K. The position accounts for 0.32% of the portfolio, ranked #58.

WFA of San Diego first reported a position in ABBV in Q2 2020 and has held it in 20 quarters since. The position peaked at $943K in Q2 2020. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

WFA of San Diego held 1,568 shares of AbbVie worth $393K as of Q2 2026.
WFA of San Diego sold 185 AbbVie shares in Q2 2026, an estimated $39.8K.
AbbVie made up 0.32% of WFA of San Diego's portfolio in Q2 2026, its #58 holding.
WFA of San Diego first reported a position in AbbVie in Q2 2020 and has held it in 20 quarters since.
WFA of San Diego's AbbVie position peaked at $943K in Q2 2020.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WFA of San Diego's 13F filing for Q2 2026, filed 14 Aug 2026.